NCT07059962 Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
| NCT ID | NCT07059962 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bodyport Inc. |
| Condition | Kidney Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 125 participants |
| Start Date | 2025-09-09 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 125 participants in total. It began in 2025-09-09 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore the use of the Bodyport Cardiac Scale in predicting worsening of events due to fluid overload in patients with kidney disease on peritoneal dialysis.
Eligibility Criteria
Inclusion Criteria: 1. Age 21 years or older 2. Able to speak and read English, or able to speak and read Spanish and has a caregiver or family member who speaks English and can provide assistance 3. Able to stand on two bare feet unassisted 4. Receiving automated peritoneal dialysis for the treatment of ESKD 5. Followed on the Vantive Sharesource Remote Patient Management Platform Exclusion Criteria: 1. Undergoing or plan to undergo hemodialysis in the next 12 months 2. Have a life expectancy of less than 12 months 3. Are pregnant or plan to become pregnant during the next 12 months 4. Weigh greater than 375 lbs 5. Planned kidney transplant within the next 12 months 6. Have an implanted neurostimulator system
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07059962 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, studying Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07059962 currently recruiting?
Yes, NCT07059962 is actively recruiting participants. Contact the research team at corey@bodyport.com for enrollment information.
Where is the NCT07059962 trial being conducted?
This trial is being conducted at Victorville, United States, Augusta, United States, Chicago, United States, Winnipeg, Canada.
Who is sponsoring the NCT07059962 clinical trial?
NCT07059962 is sponsored by Bodyport Inc.. The trial plans to enroll 125 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.